00000nas 2200000zi 4500 9.507462 CaOODSP 20221107133801 m o d f cr ||||||||||| 150406d20072015oncar p o f0 a0eng|d 2292-3136 CaOODSP eng n-cn--- H79-5E-PDF H79-5/2015E-PDF New drug pipeline monitor. Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2007-2015. Annual (Irregular) text txt rdacontent computer c rdamedia online ressource cr rdacarrier Began with 2007; ceased with 2015. "National Prescription Drug Utilization Information System (NPDUIS)." Issued also in French under title: L'observateur des médicaments émergents. "The New Drug Pipeline Monitor (NDPM) provides information on drugs currently under development that may have an impact on future drug plan expenditures in Canada. This publication contains a select list of pipeline drugs that are in Phase III clinical trials or under review by the US Food and Drug Administration (FDA) and that demonstrate the potential to have a significant clinical impact. The BioPharm Insight database is the main data source for this drug selection"--Executive summary, 2014. gccst Drugs gccst Research and development Canada. Patented Medicine Prices Review Board. L'observateur des médicaments émergents. (CaOODSP)9.503855 Meds pipeline monitor ... (CaOODSP)9.868374